ClinConnect ClinConnect Logo
Search / Trial NCT05489133

Early Psychological Intervention After Rape

Launched by ST. OLAVS HOSPITAL · Aug 3, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how an early psychological treatment called modified Prolonged Exposure Therapy (mPE) can help women who have experienced rape. Many women develop post-traumatic stress disorder (PTSD) after such traumatic events, and this study aims to see if starting therapy soon after the incident can prevent PTSD from developing. The trial will involve women aged 16 and older who have faced sexual violence and are seeking help at specific sexual assault care centers in Norway. Participants will be randomly assigned to either receive the mPE therapy or the usual care that is typically provided.

If you or someone you know is eligible to participate, you can expect to attend three to five therapy sessions, which will last about an hour each. The study is currently recruiting participants, and it’s important to note that certain conditions would exclude someone from joining, such as being under 16 years old, having severe mental health issues, or currently undergoing treatment for PTSD. The goal is to better understand how early intervention can support recovery after such a traumatic experience.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women ≥ 16 years of age
  • attending after a trauma meeting the DSM V trauma definition criterion "sexual violation" (in this context, characterized by penetration in any body orifice, by penis, finger, foreign body, but also attempted penetration leading to a sufficient mental reaction, helplessness, without control, intense fear etc.)
  • Exclusion Criteria:
  • Age \< 16 years
  • male biological gender
  • cognitive disability
  • acute psychosis
  • acute suicidal
  • severe alcohol/drug abuse
  • current treatment for PTSD
  • non-Norwegian speaking
  • total amnesia for the event

About St. Olavs Hospital

St. Olavs Hospital is a leading healthcare institution located in Trondheim, Norway, renowned for its commitment to advancing medical research and improving patient care. As a key clinical trial sponsor, the hospital is dedicated to conducting innovative research across various therapeutic areas, fostering collaboration among multidisciplinary teams of healthcare professionals and researchers. With state-of-the-art facilities and a patient-centric approach, St. Olavs Hospital aims to enhance clinical outcomes and contribute to the global body of medical knowledge through rigorous and ethically conducted clinical trials.

Locations

Fredrikstad, , Norway

Oslo, , Norway

Sandefjord, , Norway

Trondheim, , Norway

Stavanger, In, Norway

Patients applied

NW

1 patients applied

Trial Officials

Cecilie T Hagemann

Principal Investigator

St. Olavs Hospital

Joar Ø Halvorsen

Study Director

St. Olavs Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials